MAPT and Alzheimer disease: Interestingly, CSF α-Syn levels were not significantly increased in the CSF α-Syn1-AD patients at baseline, which may confirm that AD primarily involves tau or Aβ pathology and is not a synaptic nucleoprotein disease.